Aveanna Healthcare (NASDAQ:AVAH) CFO Matthew Buckhalter Sells 18,340 Shares

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) CFO Matthew Buckhalter sold 18,340 shares of the firm’s stock in a transaction on Friday, January 2nd. The stock was sold at an average price of $7.85, for a total value of $143,969.00. Following the completion of the sale, the chief financial officer directly owned 436,980 shares of the company’s stock, valued at approximately $3,430,293. This trade represents a 4.03% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.

Matthew Buckhalter also recently made the following trade(s):

• On Wednesday, December 31st, Matthew Buckhalter sold 17,289 shares of Aveanna Healthcare stock. The shares were sold at an average price of $8.18, for a total value of $141,424.02.
• On Tuesday, December 30th, Matthew Buckhalter sold 17,448 shares of Aveanna Healthcare stock. The stock was sold at an average price of $8.36, for a total value of $145,865.28.

Aveanna Healthcare Trading Down 1.1%

Shares of NASDAQ AVAH opened at $8.08 on Friday. The company has a current ratio of 1.23, a quick ratio of 1.23 and a debt-to-equity ratio of 140.39. Aveanna Healthcare Holdings Inc. has a one year low of $3.67 and a one year high of $10.32. The business has a 50-day moving average price of $8.92 and a two-hundred day moving average price of $7.49. The firm has a market capitalization of $1.69 billion, a PE ratio of 22.44 and a beta of 2.06.

Aveanna Healthcare (NASDAQ:AVAH) last posted its quarterly earnings results on Monday, May 22nd. The company reported $0.04 earnings per share (EPS) for the quarter. The business had revenue of $450.53 million during the quarter. Aveanna Healthcare had a net margin of 3.29% and a negative return on equity of 143.55%. As a group, analysts predict that Aveanna Healthcare Holdings Inc. will post -0.06 earnings per share for the current fiscal year.

Institutional Trading of Aveanna Healthcare

A number of institutional investors and hedge funds have recently modified their holdings of the company. Banque Transatlantique SA bought a new stake in shares of Aveanna Healthcare during the 1st quarter worth $25,000. Quantbot Technologies LP bought a new stake in Aveanna Healthcare during the second quarter valued at about $43,000. Diversified Trust Co bought a new position in shares of Aveanna Healthcare in the second quarter worth about $57,000. Jump Financial LLC bought a new position in shares of Aveanna Healthcare in the first quarter worth about $59,000. Finally, MQS Management LLC acquired a new position in shares of Aveanna Healthcare during the 2nd quarter worth about $59,000. 87.96% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of analysts recently issued reports on AVAH shares. UBS Group lifted their price objective on Aveanna Healthcare from $9.00 to $9.50 and gave the company a “neutral” rating in a research report on Friday, November 7th. William Blair assumed coverage on Aveanna Healthcare in a report on Monday, December 8th. They set an “outperform” rating for the company. Weiss Ratings reissued a “hold (c+)” rating on shares of Aveanna Healthcare in a research note on Monday. Royal Bank Of Canada raised their price objective on shares of Aveanna Healthcare from $8.00 to $10.00 and gave the company a “sector perform” rating in a research report on Friday, October 24th. Finally, Raymond James Financial reissued an “outperform” rating and issued a $13.00 target price on shares of Aveanna Healthcare in a research report on Friday, December 5th. Five research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the stock. Based on data from MarketBeat, Aveanna Healthcare presently has an average rating of “Hold” and an average price target of $10.69.

Trending Headlines about Aveanna Healthcare

Here are the key news stories impacting Aveanna Healthcare this week:

• Negative Sentiment: CEO Jeff Shaner sold multiple blocks (roughly 83,000+ shares across Dec. 30–Jan. 2 in the filings), at prices around $8.18–$8.36, reducing his stake by about 1–1.2% in individual trades while retaining a multi‑million‑share holding — investors may view repeated CEO sales as a negative signal. SEC filing — Jeff Shaner
• Negative Sentiment: CFO Matthew Buckhalter executed several sales (totaling ~70,000+ shares across Dec. 30–Jan. 2) at roughly $7.85–$8.36, each reducing his position by ~3.5–4%. Repeated CFO sales can raise governance/comfort concerns for short‑term holders. SEC filing — Matthew Buckhalter
• Negative Sentiment: CAO Deborah Stewart sold multiple blocks (~34,000+ shares across Dec. 30–Jan. 2) at similar price levels, trimming her stake by ~4% in reported trades while keeping a substantial holding — another senior exec sale that may pressure sentiment. SEC filing — Deborah Stewart
• Negative Sentiment: Insider Edwin C. Reisz sold multiple tranches (~51,000+ shares across Dec. 30–Jan. 2) at $7.85–$8.36, reducing his position by ~1.2% in several filings. Multiple insider sellers across ranks amplify negative interpretation. SEC filing — Edwin C. Reisz
• Negative Sentiment: Insider Patrick A. Cunningham reported several sales (~36,000+ shares across Dec. 30–Jan. 2) at similar price points, lowering his stake by ~3.6–4.1% in the disclosed trades. Collective insider selling increases perceived supply risk. SEC filing — Patrick A. Cunningham

Aveanna Healthcare Company Profile

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.